Zimmer Biomet

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Zimmer Biomet and other ETFs, options, and stocks.

About ZBH

Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. 

CEO
Ivan Tornos
CEOIvan Tornos
Employees
17,000
Employees17,000
Headquarters
Warsaw, Indiana
HeadquartersWarsaw, Indiana
Founded
1927
Founded1927
Employees
17,000
Employees17,000

ZBH Key Statistics

Market cap
18.01B
Market cap18.01B
Price-Earnings ratio
22.33
Price-Earnings ratio22.33
Dividend yield
1.06%
Dividend yield1.06%
Average volume
2.29M
Average volume2.29M
High today
$90.23
High today$90.23
Low today
$89.13
Low today$89.13
Open price
$89.63
Open price$89.63
Volume
617.49K
Volume617.49K
52 Week high
$114.44
52 Week high$114.44
52 Week low
$85.33
52 Week low$85.33

Stock Snapshot

Zimmer Biomet(ZBH) stock is priced at $90.23, giving the company a market capitalization of 18.01B. It carries a P/E multiple of 22.33 and pays a dividend yield of 1.1%.

On 2025-12-25, Zimmer Biomet(ZBH) stock moved within a range of $89.13 to $90.23. With shares now at $90.23, the stock is trading +1.2% above its intraday low and 0.0% below the session's peak.

Trading activity shows a volume of 617.49K, compared to an average daily volume of 2.29M.

Over the past 52 weeks, Zimmer Biomet(ZBH) stock has traded between a high of $114.44 and a low of $85.33.

Over the past 52 weeks, Zimmer Biomet(ZBH) stock has traded between a high of $114.44 and a low of $85.33.

ZBH News

TipRanks 3d
Zimmer Biomet: Solid Long-Term Setup but Execution Risks and Conservative Guidance Justify Hold Rating

Analyst Robbie Marcus of J.P. Morgan maintained a Hold rating on Zimmer Biomet Holdings, retaining the price target of $100.00. Claim 50% Off TipRanks Premium a...

TipRanks 3d
JPMorgan sees 2026 as ‘pivotal year’ for Zimmer Biomet

JPMorgan thinks 2026 is set up to be a “pivotal year” for Zimmer Biomet (ZBH). The analyst keeps a Neutral rating on the shares with a $100 price target Investo...

Simply Wall St 6d
How Investors Are Reacting To Zimmer Biomet Dividend Move And OneStep Digital Recovery Partnership

Zimmer Biomet Holdings, Inc. announced in the past that its Board approved a fourth-quarter 2025 cash dividend of US$0.24 per share, payable on or about January...

How Investors Are Reacting To Zimmer Biomet Dividend Move And OneStep Digital Recovery Partnership

Analyst ratings

65%

of 31 ratings
Buy
29%
Hold
64.5%
Sell
6.5%

People also own

Based on the portfolios of people who own ZBH. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.